Raphael Sommer
About Raphael Sommer
Raphael Sommer is a Clinical Scientist specializing in Cell Therapy at Bristol Myers Squibb in Boudry, Neuchâtel, Suisse. He has a diverse background in chemistry, biology, and engineering, with significant experience in clinical sciences and innovation.
Current Role at Bristol Myers Squibb
Raphael Sommer currently serves as a Clinical Scientist specializing in Cell Therapy at Bristol Myers Squibb. He commenced this role in January 2023 and is based in Boudry, Neuchâtel, Suisse. In this position, Sommer focuses on the application of integrated and multidisciplinary scientific approaches to clinical trials, leveraging his extensive background in chemistry, biology, and engineering.
Previous Experience at Novartis Institutes for BioMedical Research
Prior to his current role, Raphael Sommer held several positions at Novartis Institutes for BioMedical Research (NIBR) in Bâle, Suisse. He worked as a Clinical Scientist from 2022 to 2023. Before that, he was an Associate Clinical Scientist from 2020 to 2022, and earlier as a Postgraduate in Clinical Sciences and Innovation from 2019 to 2020. His tenure at NIBR highlighted his consistent focus on clinical trials and biomedical research.
Educational Background at EPFL
Raphael Sommer holds a Doctor of Philosophy (PhD) in Molecular Life Sciences from EPFL (École polytechnique fédérale de Lausanne), which he earned between 2015 and 2019. He also completed a Master of Science (MSc) in Life Sciences and Technology from EPFL from 2012 to 2014. Additionally, he holds a Bachelor of Science (BSc) in Chimie et Génie Chimique, completed from 2008 to 2012 at EPFL.
Research and Internships
Throughout his academic and professional journey, Raphael Sommer gained invaluable experience through various internships and research positions. He worked as a Scientific Collaborator at Innovative Medicines for Tuberculosis (iM4TB) Foundation in 2019 for two months and as a Visiting Student at the Institute for Bioscience and Biotechnology Research in Washington D.C. in 2014 for six months. He also held an internship trainee position at Debiopharm International SA in 2013 for two months in Lausanne, Suisse.